The Vaccinated had a Higher rate of Allergies and Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder, and/or a learning disability (NDD) than the Unvaccinated.
ALERT: Editors’ Note Appended 11/28/16: The survey mentioned was taken directly from the Frontiers in Public Health website. The published abstract was recently deleted from their website. The cached images of the survey has been saved on this link: READ MORE…
New Evidence of Vaccine-Associated Increases in Diabetes – Evidence of a vaccination-diabetes connection has been strengthened since 1996 by the epidemiologic investigation of J. Barthelow Classen, M.D., a former researcher at the National Institutes of Health and the founder and CEO of Classen Immunotherapies, Inc.. Dr. Classen is developing ways to prevent autoimmune disease and maintains that one reason there is a growing epidemic of diabetes in the world is because vaccines given to children at two months and older can induce immune-mediated diabetes.
Classen has analyzed mass vaccination and disease incidence data from foreign countries, which keep better records of diabetes incidence than the U.S., as well as has conducted basic science research experiments on mice and rats to support his argument. Beginning with lab experiments, he demonstrated that 8 week old rats and mice injected with DPT vaccine had a higher incidence of diabetes than those who were not injected with DPT vaccine at 8 weeks old. Then he searched for evidence in existing epidemiological data on human populations to suggest that injecting two month old babies with vaccines causes an increased incidence in diabetes.
In the May 24, 1996 New Zealand Medical Journal, Dr. Classen reported that there was a 60 percent increase in Type I diabetes (juvenile diabetes) following a massive campaign in New Zealand from 1988 to 1991 to vaccinate babies six weeks of age or older with hepatitis B vaccine. His analysis of a group of 100,000 New Zealand children prospectively followed since 1982 showed that the incidence of diabetes before the hepatitis B vaccination program began in 1988 was 11.2 cases per 100,000 children per year while the incidence of diabetes following the hepatitis B vaccination campaign was 18.2 cases per 100,000 children per year.
More Vaccines Equal More Diabetes – In the October 22, 1997 Infectious Diseases in Clinical Practice, Classen presented more data further substantiating his findings of a vaccine-diabetes connection. He reported that the incidence of diabetes in Finland was stable in children under 4 years of age until the government made several changes in its childhood vaccination schedule. In 1974, 130,000 children aged 3 months to 4 years were enrolled in a vaccine experimental trial and injected with Hib vaccine or meningococcal vaccine. Then, in 1976, the pertussis vaccine used in Finland was made stronger by adding a second strain of bacteria. During the years 1977 to 1979, there was a 64 percent increase in the incidence of Type 1 diabetes in Finland compared to the years 1970 to 1976.
EXCERPTS:
Dr Moulden died unexpectedly in November of 2013 at age 49.
Dr. Moulden resigned from his medical practice in 2007 to travel throughout North America delivering the message that every dose of any and all vaccine types causes harm to those who receive it. He stated:
| “As many know, I officially quit my medical career in 2007. I did this in order to travel around North America to do research into vaccine safety and to present my research on vaccine safety across Canada and the United States. I only spoke the truth. I was not well received.” |
During those years, he showed that many cases of Shaken Baby Syndrome were actually vaccine-related damage. His testimony freed many parents from false accusations that they had abused their infants.
FDA APPROVES SQUALENE IN FLU SHOT (Nov. 2015)
Dr. Mercola on the H1N1 vaccine containing Squalene
Novartis’s proprietary squalene adjuvant for their H1N1 vaccine is MF59. Glaxo’s is ASO3. MF59 has yet to be approved by the FDA for use in any U.S. vaccine, despite its history of use in other countries
The MF-59 adjuvant has been used in several vaccines. These vaccines, including tetanus and diphtheria, are the same vaccines frequently associated with adverse reactions. READ MORE…
VLA COMMENT: FLUAD PEDIATRIC with Squalene is being used in Canada based on literature review of experiments on the elderly 65 & older of which FLUAD is FDA approved. No doubt after experiments are done on infants and children in other countries, it will come to USA.
A review published in the journal Vaccine was produced to justify injecting the HPV vaccines into tiny babies.[2] The authors wrote:
On a global scale, vaccination of newborns and infants is well established and has developed a successful working infrastructure. The hepatitis B virus (HBV) vaccination programs offer a model for HPV introduction in which newborn and infant immunization achieves a rapid reduction in the prevalence of the HBV carrier rates in immunized cohorts of children, and of liver cirrhosis and liver cancer decades later. [Emphasis mine.]
They consider giving babies the hepatitis B vaccine on the day of birth to be a model for reducing the age of HPV vaccination. Rather than vaccinating girls shortly before or near puberty, they’re suggesting that they be vaccinated as infants. READ MORE…